BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Prognosis
53 results:

  • 1. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
    Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
    Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Updates on the genetics of multiple endocrine neoplasia.
    Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
    Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effects of Autophagy-Related Genes on the prognosis and Immune Microenvironment of Ovarian cancer.
    Zhang J; Yan H; Fu Y
    Biomed Res Int; 2022; 2022():6609195. PubMed ID: 35941978
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer.
    Zong S; Xu PP; Xu YH; Guo Y
    J Ovarian Res; 2022 Aug; 15(1):90. PubMed ID: 35915456
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PUMILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and contributes to ovarian cancer progression.
    Li X; Zhu M; Zang M; Cao D; Xie Z; Liang H; Bian Z; Zhao T; Hu Z; Xu EY
    Cell Mol Life Sci; 2022 May; 79(5):279. PubMed ID: 35507203
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance.
    Zong X; Zhang Y; Peng X; Cao D; Yu M; Wang J; Li H; Guo X; Liang H; Yang J
    Nat Commun; 2021 Jun; 12(1):3579. PubMed ID: 34117242
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. EIF3B promotes cancer progression in pancreatic cancer.
    Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
    Scand J Gastroenterol; 2021 Mar; 56(3):281-288. PubMed ID: 33459066
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?
    Asa SL; Mete O; Ezzat S
    Endocr Pathol; 2021 Mar; 32(1):3-16. PubMed ID: 33433883
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Exosomes released from M2 macrophages transfer miR-221-3p contributed to EOC progression through targeting cdkn1b.
    Li X; Tang M
    Cancer Med; 2020 Aug; 9(16):5976-5988. PubMed ID: 32590883
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
    Couvelard A; Scoazec JY
    Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. RUNX3 Promotes the Tumorigenic Phenotype in KGN, a Human Granulosa Cell Tumor-Derived Cell Line.
    Chen H; Crosley P; Azad AK; Gupta N; Gokul N; Xu Z; Weinfeld M; Postovit LM; Pangas SA; Hitt MM; Fu Y
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311113
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma.
    Oldridge DA; Truong B; Russ D; DuBois SG; Vaksman Z; Mosse YP; Diskin SJ; Maris JM; Matthay KK
    J Natl Cancer Inst; 2019 Nov; 111(11):1192-1201. PubMed ID: 30793172
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression of Cyclin E/Cdk2/p27
    Dong W; Zhu H; Gao H; Shi W; Zhang Y; Wang H; Li C; Song G; Zhang Y
    World Neurosurg; 2019 Jan; 121():e45-e53. PubMed ID: 30196178
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Reduced expression of the RNA-binding protein HuD in pancreatic neuroendocrine tumors correlates with low p27
    Kim C; Jeong DE; Heo S; Ji E; Rho JG; Jung M; Ahn S; Kim YJ; Kim YS; Nam SW; Kulkarni RN; Lee KB; Lee EK; Kim W
    J Pathol; 2018 Oct; 246(2):231-243. PubMed ID: 30014466
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical Impact of p27
    Sengul Aycicek G; Aydogan BI; Sahin M; Cansız Ersoz C; Sak SD; Baskal N
    Endocr Pathol; 2018 Sep; 29(3):250-258. PubMed ID: 29589297
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genome-wide DNA copy number analysis in clonally expanded human ovarian cancer cells with distinct invasive/migratory capacities.
    Li L; Bai H; Yang J; Cao D; Shen K
    Oncotarget; 2017 Feb; 8(9):15136-15148. PubMed ID: 28122348
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Upregulation of p27kip1 by demethylation sensitizes cisplatin-resistant human ovarian cancer SKOV3 cells.
    Zhao Y; Li Q; Wu X; Chen P
    Mol Med Rep; 2016 Aug; 14(2):1659-66. PubMed ID: 27314502
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome-wide shRNA screen.
    Kurahara H; Bohl C; Natsugoe S; Nishizono Y; Harihar S; Sharma R; Iwakuma T; Welch DR
    Int J Cancer; 2016 Aug; 139(3):628-38. PubMed ID: 27012470
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27kip1 translation.
    Zhang Y; Yu JJ; Tian Y; Li ZZ; Zhang CY; Zhang SF; Cao LQ; Zhang Y; Qian CY; Zhang W; Zhou HH; Yin JY; Liu ZQ
    Oncotarget; 2015 Sep; 6(28):25441-51. PubMed ID: 26213845
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
    Zhao Z; Li C; Xi H; Gao Y; Xu D
    Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.